<p>The radii of the circles are calculated based on the percentage of participants choosing a particular effort level over the total number of participants per country-treatment. The total number of participants per country-treatment is available in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0187840#pone.0187840.t001" target="_blank">Table 1</a>.</p
<p>The -axes are the community level of treatment, i.e. the strategy assumed chosen by all other mem...
Participants’ distribution across gender, age and academic field—Per country and total.</p
<p>. <b>(A)</b> Results from the ‘Analgesic Effect’ task. <b>(B)</b> Results from the ‘Adverse Effec...
<p>* Values are the number of patients/number of controls.</p><p>Demographic distribution of the ind...
Proportion of study participants disaggregated by the type of cancers and the country in which they ...
<p>The proportion of trials guessed correctly as a function of the number of alternative choices. Th...
The figure shows the distribution of individuals in relation to their clinical classification.</p
<p>The radial barplot shows the proportion of industry- sponsored clinical trials (in dark blue) in ...
<p>The distribution of participant's number of group identities across 22 countries.</p
<p>Distribution of minimization criteria in trial participants included in the primary endpoint anal...
<p>The top 5 conditions are presented for each region, ranked from highest to lowest based on the nu...
Countries in light grey indicate the origin of participants. Total number of participants: Primary c...
Distribution of the study participants by their demographic and clinical characteristics.</p
Distribution of study participants across TB screening countries (RadRS analysis population).</p
rating participant choice, provides unbiased estimates of the effects of the treatment or interventi...
<p>The -axes are the community level of treatment, i.e. the strategy assumed chosen by all other mem...
Participants’ distribution across gender, age and academic field—Per country and total.</p
<p>. <b>(A)</b> Results from the ‘Analgesic Effect’ task. <b>(B)</b> Results from the ‘Adverse Effec...
<p>* Values are the number of patients/number of controls.</p><p>Demographic distribution of the ind...
Proportion of study participants disaggregated by the type of cancers and the country in which they ...
<p>The proportion of trials guessed correctly as a function of the number of alternative choices. Th...
The figure shows the distribution of individuals in relation to their clinical classification.</p
<p>The radial barplot shows the proportion of industry- sponsored clinical trials (in dark blue) in ...
<p>The distribution of participant's number of group identities across 22 countries.</p
<p>Distribution of minimization criteria in trial participants included in the primary endpoint anal...
<p>The top 5 conditions are presented for each region, ranked from highest to lowest based on the nu...
Countries in light grey indicate the origin of participants. Total number of participants: Primary c...
Distribution of the study participants by their demographic and clinical characteristics.</p
Distribution of study participants across TB screening countries (RadRS analysis population).</p
rating participant choice, provides unbiased estimates of the effects of the treatment or interventi...
<p>The -axes are the community level of treatment, i.e. the strategy assumed chosen by all other mem...
Participants’ distribution across gender, age and academic field—Per country and total.</p
<p>. <b>(A)</b> Results from the ‘Analgesic Effect’ task. <b>(B)</b> Results from the ‘Adverse Effec...